ѻý

Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain

<ѻý class="mpt-content-deck">— News and commentary from the endocrinology world
MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

The Obesity Society, Obesity Action Coalition, and Obesity Medicine Association released a joint statement warning against the .

of its 1.7-mg dose of semaglutide (Wegovy), which has been in short supply since mid-December, the company said. (Reuters)

From 1999 to 2019, and hyperosmolar hyperglycemic state increased, with the biggest jumps seen in adults 65 and older. (JAMA)

Neuralace Medical announced noninvasive peripheral nerve stimulation for chronic painful diabetic neuropathy.

A study of electronic health records found an association between and increased risk of cardiovascular disease in men with hypogonadism -- a contrast to the results from the randomized TRAVERSE trial that cleared testosterone therapy of major adverse cardiac event risk. (Epic Research)

Meanwhile, hormone replacement therapy in women and the duration of its use were both linked with a . (RMD Open)

in plastics cost the U.S. roughly $250 billion in increased healthcare costs in 2018, researchers estimated in the Journal of the Endocrine Society.

Arsenic exposure -- another ? A mouse study suggested so. (Environmental Health Perspectives)

Regardless of BMI and other comorbidities, Hispanic and Latino adults with had a significantly higher risk for death. (JAMA Network Open)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.